Press release
Mantle Cell Lymphoma Therapeutics Market Trends, Insight, Company Analysis And Forecast 2033
Mantle Cell Lymphoma Therapeutics Market
The mantle cell lymphoma therapeutics market size is expected to see strong growth in the next few years. It will grow to $3.29 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to targeted therapies advancements, immunotherapy innovations, personalized medicine trends, global market expansion, increasing incidence rates. Major trends in the forecast period include immunotherapy advancements, precision medicine and biomarker development, targeted therapies for specific pathways, combination therapies, integration of artificial intelligence (ai).
Market Overview -
Mantle cell lymphoma therapeutics refers to treatment approaches and strategies used to manage mantle cell lymphoma (MCL); a type of non-Hodgkin lymphoma characterized by abnormal B-cell growth in the lymphatic system. These treatments use focused strategies like BTK and BCL2 inhibitors, which have long-lasting therapeutic effects.
Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=10813&type=smp
The Surge In Mantle Cell Lymphoma Prevalence Driving Growth In Therapeutics Market
The rise in the prevalence of mantle cell lymphoma is expected to propel the growth of the mantle cell lymphoma therapeutics market going forward. Mantle cell lymphoma (MCL) is a type of non-Hodgkin lymphoma (NHL), a cancer affecting the lymphatic system. Mantle Cell Lymphoma therapeutics help reduce the disease's prevalence by treating and managing the condition and improving patient outcomes, prolonged survival, and reduced disease burden. For instance, in December 2022, according to the National Library of Medicine, a US-based biomedical library operated by the United States Federal Government, the annual incidence of mantle cell lymphoma is one case per 200,000 people, contributing to 5% of all non-Hodgkins lymphomas. Therefore, the rise in the prevalence of mantle cell lymphoma is driving the growth of the mantle cell lymphoma therapeutics market.
Competitive Landscape -
Major companies operating in the mantle cell lymphoma therapeutics market report are AstraZeneca plc, Celgene Corporation, Johnson & Johnson Consumer Inc., Takeda Pharmaceutical Company Limited, Bayer Aktiengesellschaft, Eli Lilly and Company, Amgen Inc., GlaxoSmithKline plc, Kite Pharma Inc., Gilead Sciences Inc., AbbVie Inc., Bristol-Myers Squibb Company, Novartis AG, Merck & Co. Inc., Massive Bio Inc., Juno Therapeutics Inc., Nurix Therapeutics Inc., Janssen Biotech Inc., TG Therapeutics Inc., F. Hoffmann-La Roche AG, Astex Pharmaceuticals Inc., Astellas Pharma Inc., BeiGene Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Exelixis Inc., Hutchison China MediTech Limited, Incyte Corporation, Ionis Pharmaceuticals Inc., KalVista Pharmaceuticals Inc.
The Rise Of Targeted Therapy Drugs In The Mantle Cell Lymphoma Therapeutics Market
The development of targeted therapy drugs is a key trend gaining popularity in the mantle cell lymphoma therapeutics market. Major companies operating in the mantle cell lymphoma therapeutics market are developing new drugs for targeted therapy to sustain their position in the market. For instance, in March 2023, AstraZeneca plc., a UK-based pharmaceutical company, received approval for Calquence (acalabrutinib) from National Medical Products Administration (NMPA) to market the drug in China for adult patients who have mantle cell lymphoma (MCL). Calquence (acalabrutinib) is a selective Bruton's tyrosine kinase (BTK) inhibitor, and it is used to offer a tolerable and effective new treatment option to help control mantle cell lymphoma.
Browse Full Report @
https://www.thebusinessresearchcompany.com/report/mantle-cell-lymphoma-therapeutics-global-market-report
Key Segments -
The mantle cell lymphoma therapeutics market covered in this report is segmented -
1) By Type: Combination Therapy, Monotherapy
2) By Mechanism of Action: Bruton Tyrosine Kinase Inhibitors, Alkylating Agents, Deoxyribonucleic Acid Synthesis Inhibitors, Microtubule Inhibitors, Monoclonal Antibodies, Other Mechanisms
3) By Route of Administration: Oral, Parenteral
4) By Application: Hospital, Research Institute, Other Applications
Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mantle Cell Lymphoma Therapeutics Market Trends, Insight, Company Analysis And Forecast 2033 here
News-ID: 3478604 • Views: …
More Releases from The Business research company
Military Radars Market Emerging Trends, Growth Opportunities, Demand And Forecas …
The military radars market size has grown strongly in recent years. It will grow from $61.38 billion in 2023 to $65.26 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to national security and defense, technological advancements, threat detection and tracking, electronic warfare (ew).
The military radars market size is expected to see strong growth in the next…
Mattresses, Blinds And Shades Market Trends, Share, Growth, Analysis And Future …
The mattresses, blinds and shades market size has grown strongly in recent years. It will grow from $127.1 billion in 2023 to $137.13 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to consumer preferences, housing market, health and wellness trends, economic conditions.
The mattresses, blinds and shades market size is expected to see strong growth in the…
Laryngoscope Market Size, Share, Outlook, Growth, Volume And Forecast Report 202 …
The laryngoscope market size has grown rapidly in recent years. It will grow from $0.28 billion in 2023 to $0.31 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to medical advancements, anesthesia and intubation, healthcare infrastructure development, training and education.
The laryngoscope market size is expected to see rapid growth in the next few years. It will…
Insurance (Providers, Brokers and Re-Insurers) Market Growth, Key Players, Share …
The investigation and security services market size has grown strongly in recent years. It will grow from $388.69 billion in 2023 to $423.82 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to crime and threats, regulatory compliance, corporate security, data security.
The investigation and security services market size is expected to see strong growth in the next…
More Releases for Mantle
Mantle Cell Lymphoma Therapeutics Market: Competitive Dynamics & Global Outlook …
Market Research Report Store offers a latest published report on Mantle Cell Lymphoma Therapeutics Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
This report focuses on the key global Mantle Cell Lymphoma Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Mantle Cell Lymphoma…
Mantle Cell Lymphoma Treatment Market to See Incredible Growth By 2026
Mantle cell lymphoma is a rare type of blood cancer, which occurs due to excessive growth of lymphocytes. Mantle cell lymphoma is one of the B-cell non-Hodgkin lymphoma, which occurs as a result of formation of tumors in the lymph nodes, which enters the blood and spreads to the bone marrow, digestive tract, spleen, and liver. Common symptoms of the disease include loss of appetite, weight loss, fever, nausea, and…
Global Mantle Cell Lymphoma Treatment Market Forecast Report 2018-2025 Bayer AG, …
A detailed market study on "Global Mantle Cell Lymphoma Treatment Market" examines the performance of the Mantle Cell Lymphoma Treatment market. It encloses an in-depth Research of the Mantle Cell Lymphoma Treatment market state and the competitive landscape globally. This report analyzes the potential of Mantle Cell Lymphoma Treatment market in the present and the future prospects from various angles in detail.
The Global Mantle Cell Lymphoma Treatment Market 2018 report…
Mantle Cell Lymphoma Treatment Market Predicted to Grow at a Moderate Pace Throu …
Mantle cell lymphoma is a rare type of blood cancer, which occurs due to excessive growth of lymphocytes. Mantle cell lymphoma is one of the B-cell non-Hodgkin lymphoma, which occurs as a result of formation of tumors in the lymph nodes, which enters the blood and spreads to the bone marrow, digestive tract, spleen, and liver. Common symptoms of the disease include loss of appetite, weight loss, fever, nausea, and…
Mantle Cell Lymphoma Treatment Market 2018: Industry Analysis of Leading Players …
Mantle Cell Lymphoma Treatment Market Research 2018
A market study "Global Mantle Cell Lymphoma Treatment Market" examines the performance of the Mantle Cell Lymphoma Treatment market 2018. It encloses an in-depth Research of the Mantle Cell Lymphoma Treatment market state and the competitive landscape Globally. This report analyzes the potential of Mantle Cell Lymphoma Treatment market in the present and the future prospects from various angles in detail.
The Global Mantle Cell…
Mantle Cell Lymphoma Treatment Market - Global Industry Insights, 2025
Mantle cell lymphoma is a rare type of blood cancer, which occurs due to excessive growth of lymphocytes. Mantle cell lymphoma is one of the B-cell non-Hodgkin lymphoma, which occurs as a result of formation of tumors in the lymph nodes, which enters the blood and spreads to the bone marrow, digestive tract, spleen, and liver. Common symptoms of the disease include loss of appetite, weight loss, fever, nausea, and…
